A Case of Lichen Sclerosus et Atrophicus with Marked Fibrosis in the Dermis: Analysis of Fibrogenetic Cytokines by Reverse Transcriptase‐Polymerase Chain Reaction
2004; Wiley; Volume: 31; Issue: 2 Linguagem: Inglês
10.1111/j.1346-8138.2004.tb00526.x
ISSN1346-8138
AutoresYuichiro Tsunemi, Hironobu Ihn, Hidehisa Saeki, Kunihiko Tamaki,
Tópico(s)Hippo pathway signaling and YAP/TAZ
ResumoThe Journal of DermatologyVolume 31, Issue 2 p. 142-145 Letter to the Editor A Case of Lichen Sclerosus et Atrophicus with Marked Fibrosis in the Dermis: Analysis of Fibrogenetic Cytokines by Reverse Transcriptase-Polymerase Chain Reaction Yuichiro Tsunemi, Corresponding Author Yuichiro Tsunemi Department of Dermatology, Faculty of Medicine University of Tokyo, Tokyo, Japan Correspondence to: Yuichiro Tsunemi, M.D. Department of Dermatology Faculty of Medicine University of Tokyo 7-3-1 Hongo, Bunkyo-ku Tokyo, 113-8655, JapanSearch for more papers by this authorHironobu Ihn, Hironobu Ihn Department of Dermatology, Faculty of Medicine University of Tokyo, Tokyo, JapanSearch for more papers by this authorHidehisa Saeki, Hidehisa Saeki Department of Dermatology, Faculty of Medicine University of Tokyo, Tokyo, JapanSearch for more papers by this authorKunihiko Tamaki, Kunihiko Tamaki Department of Dermatology, Faculty of Medicine University of Tokyo, Tokyo, JapanSearch for more papers by this author Yuichiro Tsunemi, Corresponding Author Yuichiro Tsunemi Department of Dermatology, Faculty of Medicine University of Tokyo, Tokyo, Japan Correspondence to: Yuichiro Tsunemi, M.D. Department of Dermatology Faculty of Medicine University of Tokyo 7-3-1 Hongo, Bunkyo-ku Tokyo, 113-8655, JapanSearch for more papers by this authorHironobu Ihn, Hironobu Ihn Department of Dermatology, Faculty of Medicine University of Tokyo, Tokyo, JapanSearch for more papers by this authorHidehisa Saeki, Hidehisa Saeki Department of Dermatology, Faculty of Medicine University of Tokyo, Tokyo, JapanSearch for more papers by this authorKunihiko Tamaki, Kunihiko Tamaki Department of Dermatology, Faculty of Medicine University of Tokyo, Tokyo, JapanSearch for more papers by this author First published: 22 July 2014 https://doi.org/10.1111/j.1346-8138.2004.tb00526.xCitations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Tremaine RD, Miller RA: Lichen sclerosus et atrophicus, Int J Dermatol, 28: 10–16, 1989. 2Meffert JJ, Davis BM, Grimwood RE: Lichen sclerosus, J Am Acad Dermatol, 32: 393–416, 1995. 3Carli P, Moretti S, Spallanzani A, Berti E, Cattaneo A: Fibrogenic cytokines in vulvar lichen sclerosus. An immunohistochemical study, J Reprod Med, 42: 161–165, 1997. 4Dahiya R, Lee C, Haughney PC, Chui R, Ho R, Deng G: Differential gene expression of transforming growth factors α and β, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines, Urology, 48: 963–970, 1996. 5Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP: Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features, Cancer Res, 61: 8917–8923, 2001. 6Ackerman AB, Mendonça AMN, Guo Y: Lichen sclerosus et atrophicus vs. scleroderma, in AB Ackerman, AMN Mendonça, Y Guo (eds): Differential Diagnosis in Dermatopathology I, Lea & Febiger, Philadelphia, 1992, pp 62–65. 7Peterson LS, Nelson AM, Su WP: Classification of morphea (localized scleroderma), Mayo Clin Proc, 70: 1068–1076, 1995. 8Trattner A, David M, Sandbank M: Bullous morphea: A distinct entity?, Am J Dermatopathol, 16: 414–417, 1994. 9Daoud MS, Su WP, Leiferman KM, Perniciaro C: Bullous morphea: Clinical, pathologic, and immunopathologic evaluation of thirteen cases, J Am Acad Dermatol, 30: 937–943, 1994. 10Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis, N Engl J Med, 331: 1286–1292, 1994. 11Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro, Proc Natl Acad Sci USA, 83: 4167–4171, 1986. 12Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor, J Invest Dermatol, 107: 404–411, 1996. 13Igarashi A, Okochi H, Bradham DM, Grotendorst GR: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair, Mol Biol Cell, 4: 637–645, 1993. 14Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: Acysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10, J Cell Biol, 114: 1285–1294, 1991. 15Grotendorst GR: Connective tissue growth factor: A mediator of TGF-β action on fibroblasts, Cytokine Growth Factor Rev, 8: 171–179, 1997. 16Duncan MR, Frazier KS, Abramson S, et al: Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: Down-regulation by cAMP, FASEB J, 13: 1774–1786, 1999. 17Ihn H, Yamane K, Kubo M, Tamaki K: Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: Association with increased expression of transforming growth factor β receptors, Arthritis Rheum, 44: 474–480, 2001. 18Yamane K, Ihn H, Kubo M, Tamaki K: Increased transcriptional activities of transforming growth factor β receptors in scleroderma fibroblasts, Arthritis Rheum, 46: 2421–2428, 2002. 19Kikuchi K, Kadono T, Ihn H, et al: Growth regulation in scleroderma fibroblasts: Increased response to transforming growth factor-β 1, J Invest Dermatol, 105: 128–132, 1995. 20Igarashi A, Nashiro K, Kikuchi K, et al: Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis, J Invest Dermatol, 105: 280–284, 1995. 21Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A: Tumor necrosis factor α suppresses the induction of connective tissue growth factor by transforming growth factor-β in normal and scleroderma fibroblasts, J Biol Chem, 275: 15220–15225, 2000. 22Igarashi A, Nashiro K, Kikuchi K, et al: Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders, J Invest Dermatol, 106: 729–733, 1996. 23Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A: CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling, J Biol Chem, 276: 10594–10601, 2001. 24Patterson JA, Ackerman AB: Lichen sclerosus et atrophicus is not related to morphea: A clinical and histologic study of 24 patients in whom both conditions were reputed to be present simultaneously, Am J Dermatopathol, 6: 323–335, 1984. 25Farrell AM, Dean D, Charnock M, Wojnarowska F: Distribution of transforming growth factor-β isoforms TGF-β1, TGF-β2 and TGF-β3 and vascular endothelial growth factor in vulvar lichen sclerosus, J Reprod Med, 46: 117–124, 2001. 26Oikarinen A, Sandberg M, Hurskainen T, Kinnunen T, Kallioinen M: Collagen biosynthesis in lichen sclerosus et atrophicus studied by biochemical and in situ hybridization techniques, Acta Derm Venereol Suppl (Stockh), 162: 3–12, 1991. 27Griffiths MR, Priestley GC: A comparison of morphea and lichen sclerosus et atrophicus in vitro: The effects of para-aminobenzoate on skin fibroblasts, Acta Derm Venereol, 72: 15–18, 1992. 28Sporn MB, Roberts AB: Transforming growth factor-β: Recent progress and new challenges, J Cell Biol, 119: 1017–1021, 1992. 29Dahler AL, Cavanagh LL, Saunders NA: Suppression of keratinocyte growth and differentiation by transforming growth factor β1 involves multiple signaling pathways, J Invest Dermatol, 116: 266–274, 2001. 30Kondo S, Hozumi Y, Maejima H, Aso K: Organ culture of psoriatic skin: Effect of TGF-α and TGF-β on epidermal structure in vitro, Arch Dermatol Res, 284: 150–153, 1992. Citing Literature Volume31, Issue2February 2004Pages 142-145 ReferencesRelatedInformation
Referência(s)